We are live on ! Find out more
IMGN

Immunogen Inc
IMGN

Delisted

IMGN was delisted on the 9th of February, 2024.

Back to rankings

1 hedge funds and large institutions have $269 invested in Immunogen Inc in 2026 Q1 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1 → 1 (0)

0% more capital invested

Capital invested by funds: $269 → $269 ($0)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

IMGN Hedge Fund Activity: Q1 2026 in Review

1 of the 8,206 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q1 2026, worth a combined $269 — unchanged from a quarter earlier.

Fund positioning in IMGN was balanced in Q1 2026: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held Immunogen Inc (IMGN) as of Q1 2026, unchanged from Q4 2025.
  • Funds reported $269 of Immunogen Inc stock for Q1 2026, unchanged quarter-over-quarter.
  • 0 funds opened new Immunogen Inc positions in Q1 2026 and 0 closed out.

Based on aggregated 13F filings for Q1 2026.